- Home
- IRIX vs EDSA Comparison
IRIX vs EDSA Comparison
Compare IRIX & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRIX
- EDSA
- Stock Information
- Founded
- IRIX 1989
- EDSA 2015
- Country
- IRIX United States
- EDSA Canada
- Employees
- IRIX N/A
- EDSA N/A
- Industry
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- IRIX Health Care
- EDSA Health Care
- Exchange
- IRIX Nasdaq
- EDSA Nasdaq
- Market Cap
- IRIX 16.5M
- EDSA 15.9M
- IPO Year
- IRIX 1996
- EDSA N/A
- Fundamental
- Price
- IRIX $1.12
- EDSA $2.26
- Analyst Decision
- IRIX
- EDSA Strong Buy
- Analyst Count
- IRIX 0
- EDSA 2
- Target Price
- IRIX N/A
- EDSA $13.00
- AVG Volume (30 Days)
- IRIX 172.5K
- EDSA 24.6K
- Earning Date
- IRIX 08-12-2025
- EDSA 08-08-2025
- Dividend Yield
- IRIX N/A
- EDSA N/A
- EPS Growth
- IRIX N/A
- EDSA N/A
- EPS
- IRIX N/A
- EDSA N/A
- Revenue
- IRIX $49,744,000.00
- EDSA N/A
- Revenue This Year
- IRIX $9.61
- EDSA N/A
- Revenue Next Year
- IRIX N/A
- EDSA N/A
- P/E Ratio
- IRIX N/A
- EDSA N/A
- Revenue Growth
- IRIX 0.09
- EDSA N/A
- 52 Week Low
- IRIX $0.78
- EDSA $1.55
- 52 Week High
- IRIX $2.14
- EDSA $5.00
- Technical
- Relative Strength Index (RSI)
- IRIX 42.12
- EDSA 54.45
- Support Level
- IRIX $1.27
- EDSA $2.02
- Resistance Level
- IRIX $1.34
- EDSA $2.27
- Average True Range (ATR)
- IRIX 0.08
- EDSA 0.14
- MACD
- IRIX -0.03
- EDSA -0.01
- Stochastic Oscillator
- IRIX 10.85
- EDSA 57.14
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.